Showing results (251-260 of 377) with videos related to

Sort By:
Pageof 38
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causalityL Ebony Boulware, Yongmei Liu, Nancy E Fink, et al.
Clinical Trials (London, England)|April 24, 2021
Randomized comparison of two interventions to enhance understanding during the informed consent process for researchHolly A Taylor, Daphne Washington, Nae-Yuh Wang, et al.
Health Services Research|March 29, 2008
Testing for statistical discrimination by race/ethnicity in panel data for depression treatment in primary careThomas G McGuire, John Z Ayanian, Daniel E Ford, et al.
Mental Health Services Research|February 1, 2003
Burden of illnessTom McGuire, Kenneth B Wells, Martha L Bruce, et al.
Arthritis and Rheumatism|March 4, 2008
High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptomsBrett D Thombs, Samantha Fuss, Marie Hudson, et al.
International Journal of Psychiatry in Medicine|June 28, 2005
Patient characteristics associated with participation in a practice-based study of depression in late life: the Spectrum studyJoseph J Gallo, Hillary R Bogner, Joseph B Straton, et al.
Annals of Surgical Oncology|November 9, 2011
Adverse effects of smoking on postoperative outcomes in cancer patientsCsaba Gajdos, Mary T Hawn, Elizabeth J Campagna, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2012
Psychiatrist-patient verbal and nonverbal communications during split-treatment appointmentsMario Cruz, Debra Roter, Robyn Flaum Cruz, et al.
Tobacco Control|November 30, 2006
Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stickSharon Milberger, Ronald M Davis, Clifford E Douglas, et al.
Archives of General Psychiatry|February 13, 2003
Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United StatesGail L Daumit, Rosa M Crum, Eliseo Guallar, et al.
Pageof 38